Sonoma Pharmaceuticals
SNOA
#11061
Rank
HK$42.44 M
Marketcap
HK$8.86
Share price
1.80%
Change (1 day)
-71.47%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -HK$10.97 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are HK$21.92 Million. In 2025 the company made an earning of -HK$21.7 Million, an increase over its 2024 earnings that were of -HK$35.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$10.97 Million-49.48%
2025 -HK$21.7 Million-38.02%
2024 -HK$35.02 Million0.54%
2023 -HK$34.83 Million-31.5%
2022 -HK$50.84 Million16.86%
2021 -HK$43.51 Million194.32%
2020 -HK$14.79 Million-58.76%
2019 -HK$35.84 Million-65.66%
2018 -HK$0.11 Billion4.84%
2017 -HK$99.56 Million-2.17%
2016 -HK$0.11 Billion32.12%
2015 -HK$77.03 Million-307.74%
2014 HK$37.07 M-197.5%
2013 -HK$38.03 Million
2010 -HK$59.42 Million-14.02%
2009 -HK$69.11 Million-57.28%
2008 -HK$0.17 Billion-8.03%
2007 -HK$0.18 Billion3.85%
2006 -HK$0.17 Billion39.31%
2005 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$0.63 Billion 5,577.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA